Speaker
Co-Founder & Chief Technology Officer, Wayfinder Biosciences
David Sparkman-Yager, Co-Founder & Chief Technology Officer at Wayfinder Biosciences, is speaking at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “Optimization & Functional Characterization of MYC RNA-Targeting Small Molecules”.
10–12 Nov 2026Boston, United States of America
Associate Director, Early Discovery Chemistry, PTC Therapeutics
Professor & Associate Chair of Graduate Affairs, University of Colorado Boulder
Chief Scientific Officer, Dewpoint Therapeutics
Head of Cancer Biology, EPICS Therapeutics
Senior Principal Scientist & Research Fellow, Pfizer
Head of Small Molecules Medicinal Chemistry, Sanofi
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by David Sparkman-Yager, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].